“…Members of this genus are now known to share many phenotypic characteristics and to constitute a distinct phyletic line, and they are currently assigned to over 450 validly described species Embley & Stackebrandt, 1994;Goodfellow et al, 1997). It is also clear that minimal standards for the description of Streptomyces species need to be based on a judicious selection of genotypic and phenotypic properties Chun et al, 1997b;Labeda et al, 1997;Kim et al, 1996Kim et al, , 1998Kim et al, , 1999. Streptomycetes continue to be a rich source of novel bioactive compounds, including antibiotics, antitumour agents and enzymes (Berdy, 1995;Chun et al, 1997b;Labeda et al, 1997).…”